Form D · Biotechnology

Rodeo Therapeutics Corp

Seattle, WA · CIK 0001712341

Offering snapshot reported Apr 2, 2020 · SEC filing

Reported sold
$8.95M
Offering amount: $8.95M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 26, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.48M$8.95MDec 10, 2018: $3,685,714.00Dec 10, 2018Mar 29, 2019: $7,949,999.00Mar 29, 2019Apr 2, 2020: $8,950,000.00Apr 2, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$7,949,999 → $8,950,000
  • Reported investors8 → 9

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 2, 2020Amendment$8,950,000$1,000,001vs Mar 29, 20199SEC filing
Mar 29, 2019Amendment$7,949,999$4,264,285vs Dec 10, 20188SEC filing
Dec 10, 2018Initial$3,685,714No comparison6SEC filing
Aug 2, 2017Initial$5,354,000No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-327473

Source: Form D, filed Apr 2, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Margarita Chavez Director
Steve Gillis Director
Katie Hewitt Director
Ian Howes Executive
Thong Le Director, Executive, Promoter
Joel Marcus Director
Sanford Markowitz Director
Kendall Mohler Executive
Lindsay Rayle Executive, Promoter
Suzanne Rettenmier Executive
David Schubert Executive
James Sullivan Director
Asish Xavier Director
Tadataka Yamada Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2815 Eastlake Avenue East, Suite 300
Seattle, WA, 98102